Monograph
J01DB01 - Cefalexin |
Propably not porphyrinogenic |
PNP |
Rationale
Not metabolised. No data pointing to CYP interaction.
Chemical description
Perorally used cephalosporin (500 mg x 2) antibiotic used in uncomplicated urinary tract infections, skin and soft tissue infections and in pharyngotonsillitis where penicillin V has shown to be without effect. No data pointing to CYP-interaction. Excreted in unchanged form by the kidneys. South African list: use with caution. Australian list: unsafe, conflicting evidence. Drug Consult: safe.
IPNet drug reports
Uneventful use reported in 8 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Keforal 500 mg, filmomhulde tabletten 
Keforal 500 mg compr. pellic. 
CEFALEXINA NORMON 500 mg CAPSULAS DURAS · Cefalexina Reiwa Healthcare 250 mg Polvo Para Suspension Oral efg · Cefalexina Reiwa Healthcare 500 mg Capsulas Duras efg · Kefloridina Forte 500 mg Capsulas Duras · Torlasporin Capsulas 
Ceporex · Keforal 
CEFALEXINA ARENA 250 mg · CEFALEXINA ARENA 500 mg · CEFALEXINA ATB 250 mg · CEFALEXINA ATB 500 mg · KEFLEX 250 mg/5 ml 
Cefalexin · Ceporex · Keflex 
Keflex 
Keflex 
Cefaleksyna TZF 
Keforal 
Keflex 
Kefalex · Kefexin · Xefal 
Cefaleksin HF · Cefalexin Alkaloid® · Cefalexin Remedica · Palitrex®
© NAPOS 2025